Hua Medicine (Shanghai) Ltd. (OTCMKTS:HUMDF – Get Free Report) was the target of a large decline in short interest during the month of June. As of June 30th, there was short interest totaling 13,945 shares, a decline of 40.1% from the June 15th total of 23,273 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ? days.
Hua Medicine (Shanghai) Stock Performance
Shares of HUMDF stock opened at C$0.34 on Friday. Hua Medicine has a twelve month low of C$0.34 and a twelve month high of C$0.50. The stock has a 50 day moving average of C$0.38 and a 200 day moving average of C$0.41.
Hua Medicine (Shanghai) Company Profile
Hua Medicine (Shanghai) is a clinical-stage biopharmaceutical company focused on the research, development and commercialization of innovative treatments for Type 2 diabetes and related metabolic disorders. The company’s pipeline comprises both oral and injectable candidates that leverage novel biological targets and proprietary chemistry to improve glycemic control, minimize side effects and enhance patient adherence.
Founded and headquartered in Shanghai, Hua Medicine has established research hubs and strategic partnerships across Asia and Europe.
Further Reading
- Five stocks we like better than Hua Medicine (Shanghai)
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Hua Medicine (Shanghai) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hua Medicine (Shanghai) and related companies with MarketBeat.com's FREE daily email newsletter.
